BBVA USA’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
Other funds holding CAH
BBVA USA's CAH Position: Q3 2021 in Review
BBVA USA increased its Cardinal Health (CAH) stake by 0.83% in Q3 2021, buying an estimated $542 and bringing the position to 1,221 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #623.
BBVA USA first reported a position in CAH in Q2 2021 and has held it in 2 quarters since. The position peaked at $69K in Q2 2021. 748 funds tracked by Wall St. Rank hold CAH as of Q3 2021.
- BBVA USA held 1,221 shares of Cardinal Health worth $60K as of Q3 2021.
- BBVA USA bought 10 Cardinal Health shares in Q3 2021, an estimated $542.
- Cardinal Health made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #623 holding.
- BBVA USA first reported a position in Cardinal Health in Q2 2021 and has held it in 2 quarters since.
- BBVA USA's Cardinal Health position peaked at $69K in Q2 2021.
- 748 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2021.
Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.